The prevalence and predictors of an abnormal ankle-brachial index in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial

Martin Rutter, Premranjan P. Singh, J. Dawn Abbott, Manuel S. Lombardero, Kim Sutton-Tyrrell, Gail Woodhead, Lakshmi Venkitachalam, Nicholas P. Tsapatsaris, Thomas C. Piemonte, Rodrigo M. Lago, Martin K. Rutter, Richard W. Nesto

    Research output: Contribution to journalArticlepeer-review

    Abstract

    OBJECTIVE - To examine ankle-brachial index (ABI) abnormalities in patients with type 2 diabetes and coronary artery disease (CAD). RESEARCH DESIGN AND METHODS - An ABI was obtained in 2,240 patients in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial. ABIs were classified as: normal, 0.91-1.3; low, ≤0.9; high, >1.3; or noncompressible artery (NC). Baseline characteristics were examined according to ABI and by multivariate analysis. RESULTS - ABI was normal in 66%, low in 19%, and high in 8% of patients, and 6% of patients had NC. Of the low ABI patients, 68% were asymptomatic. Using normal ABI as referent, low ABI was independently associated with smoking, female sex, black race, hypertension, age, C-reactive protein, diabetes duration, and lower BMI. High ABI was associated with male sex, nonblack race, and higher BMI; and NC artery was associated with diabetes duration, higher BMI, and hypertension. CONCLUSIONS - ABI abnormalities are common and often asymptomatic in patients with type 2 diabetes and CAD. © 2011 by the American Diabetes Association.
    Original languageEnglish
    Pages (from-to)464-467
    Number of pages3
    JournalDiabetes Care
    Volume34
    Issue number2
    DOIs
    Publication statusPublished - Feb 2011

    Fingerprint

    Dive into the research topics of 'The prevalence and predictors of an abnormal ankle-brachial index in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial'. Together they form a unique fingerprint.

    Cite this